Thursday, 13 October 2022
Print
| DAY 1 | Auditorium | DAY 1 |
| DAY 1 | Auditorium | DAY 1 |
| 9:00 | 9:00: | |
| 9:05: | 9:05: | |
| 9:10: | 9:10: | |
| 9:15: | 9:15: | |
| 9:20: | 9:20: | |
| 9:25: | 9:25: | |
| 9:30: | Registration | 9:30: |
| 9:35: | 9:35: | |
| 9:40: | 9:40: | |
| 9:45: | 9:45: | |
| 9:50: | 9:50: | |
| 9:55: | 9:55: | |
| 10:00 | Event Welcome 10:00 (10 mins) Louise Affleck, PerkinElmer |
10:00 |
| 10:05 | 10:05 | |
| 10:10 | Development of a human iPSC macrophage assay platform to validate neuroimmune targets for therapeutic intervention in Alzheimer’s disease 10:10 (30 mins) Emma Mead, University of Oxford-ODDI |
10:10 |
| 10:15 | 10:15 | |
| 10:20 | 10:20 | |
| 10:25 | 10:25 | |
| 10:30 | 10:30 | |
| 10:35 | 10:35 | |
| 10:40 | Ready to Use Cell Based assays for Research, Drug Discovery and Beyond 10:40 (5 mins) Andrew Green — Eurofins Discovery |
10:40 |
| 10:45 | Enhancing Confidence in Primary Immune Cell Assays 10:45 (30 mins) Jonathan Ellery, Sitryx Therapeutics Ltd |
10:45 |
| 10:50 | 10:50 | |
| 10:55 | 10:55 | |
| 11:00 | 11:00 | |
| 11:05 | 11:05 | |
| 11:10 | 11:10 | |
| 11:15 | Integrating technologies to understand mitophagy in Parkinson’s disease 11:15 (30 mins) Brent Ryan, University of Oxford |
11:15 |
| 11:20 | 11:20 | |
| 11:25 | 11:25 | |
| 11:30 | 11:30 | |
| 11:35 | 11:35 | |
| 11:40 | 11:40 | |
| 11:45 | Networking |
11:45 |
| 11:50 | 11:50 | |
| 11:55 | 11:55 | |
| 12:00 | 12:00 | |
| 12:05 | 12:05 | |
| 12:10 | 12:10 | |
| 12:15 | 12:15 | |
| 12:20 | 12:20 | |
| 12:25 | 12:25 | |
| 12:30 | 12:30 | |
| 12:35 | 12:35 | |
| 12:40 | 12:40 | |
| 12:45 | 12:45 | |
| 12:50 | 12:50 | |
| 12:55 | 12:55 | |
| 1:00 | 1:00: |